Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Aug;31(4):511-522.
doi: 10.1007/s40620-017-0447-1. Epub 2017 Oct 9.

Pathophysiology, diagnosis and treatment of inherited distal renal tubular acidosis

Nilufar Mohebbi  1   2 , Carsten A Wagner  3   4
Affiliations
Free article
Review

Pathophysiology, diagnosis and treatment of inherited distal renal tubular acidosis

Nilufar Mohebbi et al. J Nephrol. 2018 Aug.
Free article

Abstract

Distal renal tubular acidosis (dRTA) is a tubular disorder with a primary defect of urinary acidification and acid excretion in the collecting duct system. Consequently, patients develop hyperchloremic metabolic acidosis with an inappropriately alkaline urine. Inherited forms of dRTA are due to mutations in at least three distinct genes: SLC4A1, ATP6V1B1, ATP6V0A4. Mutations in SLC4A1-(AE1) are inherited either in an autosomal dominant manner or in a recessive one. ATP6V1B and ATP6V0A4 mutations affect two different subunits of the vacuolar H+-ATPase proton-pump, the B1 and a4 subunits, and are inherited in an autosomal recessive manner. Clinical manifestations of inherited forms of dRTA usually occur during infancy or childhood. However, heterozygous carriers of ATP6V1B1 and ATP6V0A4 mutations may have a higher risk of developing nephrolithiasis and nephrocalcinosis in adulthood, respectively. In full forms of dRTA, patients may present with mild clinical symptoms, such as mild metabolic acidosis and incidental detection of kidney stones, as well as with more severe manifestations such as failure to thrive, severe metabolic acidosis, and nephrocalcinosis. Progressive sensorineural hearing loss develops in the majority of patients with recessive dRTA (ATP6V1B1 and ATP6V0A4 mutations). Some patients with recessive dRTA may also develop abnormal widening of the vestibular aqueduct. This review will discuss our current understanding of the pathophysiology of inherited forms of dRTA, diagnosis and prognosis of patients, and therapy.

Keywords: Alkali; Hearing loss; Hypokalemia; Mutation; Nephrocalcinosis; Proton pump.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. J Med Genet. 2002 Nov;39(11):796-803 - PubMed
    1. J Nephrol. 2017 Jun;30(3):455-460 - PubMed
    1. Clin Genet. 2013 Mar;83(3):274-8 - PubMed
    1. J Am Soc Nephrol. 2016 May;27(5):1544-54 - PubMed
    1. Nephrol Dial Transplant. 2015 May;30(5):770-81 - PubMed

MeSH terms

Substances